Rigel Pharmaceuticals Down 28.8% Since SmarTrend's Sell Recommendation
Nov 06, 2009 (SmarTrend(R) Spotlight via COMTEX) --
Company: Rigel Pharmaceuticals, Inc. (RIGL)
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Rigel Pharmaceuticals (NASDAQ:RIGL) on July 24, 2009 at $10.11.
Since then, Rigel Pharmaceuticals has returned 28.8% as of today's recent price of $7.19. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Copyright (C) 2009 Comtex SmarTrend(R). All rights reserved
News Provided by COMTEX
Company: Rigel Pharmaceuticals, Inc. (RIGL)
Related terms: market, nasdaq, pharmaceuticals, profit, securities, trial
